Medical device makers including Abbott, Johnson & Johnson and Medtronic want an exemption from Trump tariffs that could hit ...

Duato discusses the split of the business, dealing with the scrutiny brought about by lawsuits, and 2025 priorities.

Intra-Cellular Therapies makes Caplyta, a once-daily pill for adults with schizophrenia and bipolar-related depression ...

Johnson & Johnson is normally a good buy for its dividend and the stability it offers. Over the past five years, however, the ...

We recently compiled a list of the Retirement Stock Portfolio: 10 Healthcare Stocks to Buy. In this article, we are going to ...

Johnson & Johnson (NYSE: JNJ) didn't have an exceptional 2024; in fact, it was one of the worst-performing stocks on the ...

Johnson & Johnson (NYSE: JNJ) shares dipped slightly before hours today on fourth-quarter results that topped the consensus forecast.

Johnson & Johnson (JNJ) is a Medical stock that has seen a price change of 0.45% so far this year. The world's biggest maker of health care products is currently shelling out a dividend of $1.24 ...

In the latest trading session, Johnson & Johnson (JNJ ... world's biggest maker of health care products has risen by 0.15% in the past month, leading the Medical sector's loss of 2.46% and ...